HEATHER LARSON: Open Payments
NPI 1003249269 · ORCHARD PARK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,919 in 220 payments from 22 companies in 2025. Trend: 2023 $2,755 · 2024 $3,133 · 2025 $3,919
Food & beverage: $3,899Education: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $1,018 |
| Janssen Biotech, Inc. | 38 | $494 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $444 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 26 | $346 |
| PFIZER INC. | 22 | $328 |
| Lilly USA, LLC | 20 | $294 |
| Regeneron Healthcare Solutions, Inc. | 6 | $190 |
| QOL Medical, LLC | 10 | $175 |
| GENZYME CORPORATION | 4 | $110 |
| Ardelyx, Inc. | 4 | $86 |
Products named: TREMFYA, RINVOQ, XIFAXAN, VELSIPITY, DUPIXENT, ENTYVIO, CREON, OMVOH.
Industry payments across NY — which companies pay providers there.
